Evidence briefs, limitations, and testable next steps
Urolithin A has a biologically plausible route to healthier aging, but evidence remains mainly mechanistic, cellular, and animal-based, without proof of longer human survival.
Ethical analyses identify accountability, explanation fidelity, conflicts of interest, privacy, safety monitoring, and clinician–patient roles as major risks; implementation evidence remains system-specific.
The narrative review coherently links UV damage to skin carcinogenesis, but lacks a systematic search, original data, quantitative synthesis, and a reproducible risk-estimation method.
Phenotypic clusters may reflect different targets—distal axons, dorsal-root-ganglion neurons, or pain-processing networks—yet proposed mechanisms remain heterogeneous and require longitudinal validation.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.
Explore by Goal
Trending